Episode Details

In a world where biology isn't clean code, but a "blind mechanic trying to swap a spark plug while the engine redlines," auditors Marcus and Katie dissect the Q-One 2026 metrics for Beam Therapeutics. What appears on the surface to be a "miraculous" base editing "surgical strike" for Alpha-1 Antitrypsin Deficiency, quickly unravels under Marcus's cynical lens. He argues the elegant science is a "bespoke suit tailored for a ghost," highlighting the messy reality of in-vivo gene surgery, where the "miracle cure" is trapped in the liver like a forgotten delivery truck, failing to reach critical organs like the lungs, and leaving a trail of "Grade 4 ALT Elevations"—the patient's internal engine "seizing up."